BioLuminate, Inc. is a private, development-stage San Jose start-up firm that is developing, in collaboration with NASA Ames and Lawrence Livermore National Laboratory (LLNL), a "smart probe" that provides real-time breast cancer detection data to physicians, and may serve as a cancer therapy delivery device when cancer is found. The company has an exclusive license to NASA's "Smart Surgical Probe" technology for all cancer applications and has the exclusive rights to develop Lawrence Livermore National Laboratory's optical imaging and probing technology for all cancer detection applications. The BioLuminate project team includes LLNL scientists, Soquel Technology (optical design), Westar Design (systems engineering and software) and ALARA Inc (regulatory consulting). BioLuminate began formal operations in April 2000, following its selection as the exclusive licensee of NASA's "Smart Surgical Probe" technology for all cancer applications.
Prof. Hongxia Wang
We speak with Professor Hongxia Wang from QUT about a new project that hopes to utilize graphene and other low-cost carbon materials to produce commercially viable, ultra low-cost, flexible perovskite solar cells.
Moti Segev & Vlad Shalaev
In this interview, AzoNano speaks to Professor Moti Segev and Professor Vladimir Shalaev, who made surprising discoveries about photonic time crystals that challenge existing research and theories.
Siyu Chen, Ph.D.
In this interview, we discuss a new approach to surface-enhanced Raman spectroscopy that utilizes nano-pockets to capture target molecules, ensuring a highly sensitive way to detect chemical processes.
This product profile from Merck outlines information about ultrastable fluorescent silica nanobeads.
The ClearView scintillator camera that elevates your everyday transmission electron microscopy (TEM).
Achieve high-throughput co-localized imaging and in-situ nanoindentation with Bruker’s Hysitron PI 89 Auto SEM.